In June 2021, the U.S. Food and Drug Administration (FDA) granted approval for Semaglutide as a weight loss treatment. Since then, countless individuals have experienced remarkable transformations with this innovative approach to weight management. Now, it's your opportunity to achieve similar success at Balance Wellspace, conveniently located in Denver, Colorado.

Receive Your $300 Discount on Medical Weight Loss When You Sign Up by May 15th

Semaglutide for Weight Loss

About Semaglutide:

Semaglutide, known for its efficacy in treating Type 2 Diabetes, garnered attention for its unexpected ability to aid in weight loss. Following FDA approval in 2021, Semaglutide has empowered thousands to shed excess weight effectively.

Weight Loss Results:

Clinical studies have demonstrated that Semaglutide users can achieve weight loss ranging from 12% to 20% of their initial weight. At Balance Wellspace, our dedicated team conducted an eight-week program with a group of eight participants in Denver, resulting in a combined weight loss of 152 lbs., with minimal side effects. One participant successfully reached their target weight and completed the program, while seven others continue to progress toward their goals.

How Semaglutide Works:

Semaglutide acts as a GLP-1 agonist, mimicking the natural hormone GLP-1. By slowing stomach emptying and signaling fullness to the brain, Semaglutide reduces food intake and suppresses appetite, facilitating weight loss.


Semaglutide is administered through injections, with doses ranging from 0.25 mg to 2.4 mg. Our medical provider at Balance Wellspace in Denver monitors your progress weekly, adjusting the dosage to optimize results tailored to your individual needs.

Side Effects and Safety:

While gastrointestinal side effects like nausea, heartburn, and constipation are common, Semaglutide remains a safe option for weight loss with fewer side effects compared to other medications. Our team provides guidance on managing side effects through lifestyle adjustments and medication support.

Candidate Eligibility:

Semaglutide is suitable for individuals diagnosed as obese or overweight, or with Type 2 Diabetes, high cholesterol, or high blood pressure. However, it's not recommended for those with a history of Medullary Thyroid Carcinoma, Multiple Endocrine Neoplasia Syndrome Type 2, known Semaglutide allergy, breastfeeding, or pregnancy.
To determine if Semaglutide is right for you, schedule a consultation at Balance Wellspace in Denver. Take the first step towards achieving your weight loss goals with our comprehensive Semaglutide program.
map-markercrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram